AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 102 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $7,407,000 | -4.8% | 163,324 | -20.5% | 0.81% | +4.4% |
| Q4 2016 | $7,779,000 | -25.2% | 205,523 | -25.5% | 0.77% | -28.3% |
| Q3 2016 | $10,405,000 | +22.7% | 275,714 | -42.8% | 1.08% | +7.7% |
| Q2 2016 | $8,479,000 | +138.7% | 481,769 | +64.9% | 1.00% | +127.2% |
| Q1 2016 | $3,552,000 | -54.8% | 292,140 | -34.1% | 0.44% | -57.3% |
| Q4 2015 | $7,861,000 | 0.0% | 443,125 | 0.0% | 1.03% | +0.8% |
| Q3 2015 | $7,861,000 | -56.9% | 443,125 | -57.2% | 1.02% | -52.3% |
| Q2 2015 | $18,257,000 | +77.6% | 1,034,400 | +215.5% | 2.15% | +93.1% |
| Q1 2015 | $10,277,000 | – | 327,912 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |